AbCellera Biologics (ABCL) Earnings Date & Reports

AbCellera Biologics Inc is an antibody discovery and development engine thatâ€™s specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ABCL is expected to report earnings to rise 5.58% to -12 cents per share on May 13

AbCellera Biologics ABCL Stock Earnings Reports

Q1'25

Est.

$-0.13

Q4'24

Beat

by $0.01

Q3'24

Beat

by $0.01

Q2'24

Beat

by $0.01

Q1'24

Missed

by $0.02

The last earnings report on February 27 showed earnings per share of -11 cents, beating the estimate of -12 cents. With 4.07M shares outstanding, the current market capitalization sits at 661.53M.

View a ticker or compare two or three

Compare

ABCL